NCT06999967View on ClinicalTrials.gov

Stanford-Lucidify EEG Delirium Study

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

May 30, 2026

Conditions
DeliriumCognitive Dysfunction
Interventions
DIAGNOSTIC_TEST

Electroencephalogram (EEG)

All study subjects will undergo monitoring via a portable electroencephalogram (pEEG), the CGX EEG system (a Research-grade 2-Channel EEG device) to measure the brainwaves of patients admitted to Stanford Medical Center. Investigators will then use the Lucidify software to allow for the interpretation of obtained brainwaves for the detection of delirium .

Trial Locations (1)

94305

Stanford Hospital and Clinics, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT06999967 - Stanford-Lucidify EEG Delirium Study | Biotech Hunter | Biotech Hunter